SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 5 — Preventive Visit — Frances Burney — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientFrances Burney
Date of birth1752-06-13
IdentifiersMRN HR-EN013-SYN-TD; SSN (made up) 000-13-9108
Document date1811-10-29
AuthorHarriet Pell, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Adult preventive visit; no new complaints. [S]

History of Present Illness

Mrs. Burney returns for her yearly preventive visit, ten days after starting anastrozole and four weeks after her right mastectomy. The seroma did not recur after one aspiration, and her wound has healed. Her shoulder movement is nearly full with daily exercises. She has had no hot flashes or joint aches yet on anastrozole and takes vitamin D daily. She walks 30 minutes a day and has begun writing again in the mornings. She completed the health risk assessment before the visit. [S]

ElementDetail
VisitAdult preventive visit, age 59
Active conditionsRight breast cancer after mastectomy, on anastrozole; low bone mass
MedicinesAnastrozole 1 mg daily; vitamin D3 1000 units daily
Recent eventsSeroma aspirated once, three weeks ago; resolved
Functional statusIndependent; walking 30 minutes a day

Health risk assessment. Completed by the patient before the visit and reviewed during the visit. [S]

DomainFinding
Self-rated healthGood, and recovering well from surgery
PsychosocialClose to her husband and son; many friends visit; no financial strain; feels safe at home
BehavioralNever smoker; a glass of wine with dinner two or three times a week; walks 30 minutes a day; diet with dairy most days
Activities of daily livingIndependent in all
Instrumental activities of daily livingManages her own medicines, money, correspondence, and household
Home safetySmoke detectors working; wears a seat belt; no falls
Hearing and visionReading glasses; eye examination last year; no hearing concern
SleepAbout seven hours a night

Review of Systems

SystemResultFinding
ConstitutionalNegativeWeight stable; no fever or night sweats
EyesNegativeNo change in vision
Ears, nose, mouth, and throatNegativeNo hearing change
CardiovascularNegativeNo chest pain, palpitations, or leg swelling
RespiratoryNegativeNo cough or breathlessness
BreastNegativeNo lump or change in the left breast; right chest wall healing
GastrointestinalNegativeRegular bowels; no blood
GenitourinaryNegativeNo vaginal bleeding, dryness, or urinary symptoms
MusculoskeletalNegativeNo joint aches or bone pain; right shoulder nearly full movement
IntegumentaryNegativeWound healed; no new skin lesions
NeurologicalNegativeNo numbness of the arm beyond a small patch under the axilla
PsychiatricNegativeMood good; PHQ-2 score 0

12 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Acetaminophen 500 mg oral tablet, two tablets (1000 mg) by mouth every 6 hours for pain after surgery, no more than 3000 mg a dayTwo tablets every 6 hoursOral route1811-09-30 to 1811-10-14completedS
Ibuprofen 400 mg oral tablet, one tablet by mouth every 8 hours with food for five days after surgeryOne tablet every 8 hours with foodOral route1811-09-30 to 1811-10-05completedS
Anastrozole 1 mg oral tablet, one tablet by mouth once daily, planned for five yearsOne tablet once dailyOral route1811-10-19activeS
Cholecalciferol (vitamin D3) 1000 units oral tablet, one tablet by mouth once dailyOne tablet once dailyOral route1811-10-19activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
1811-10-29Body height160cmS
1811-10-29Body weight61.2kgS
1811-10-29Body mass index (BMI) [Ratio]23.9kg/m2S
1811-10-29Systolic blood pressure120mm[Hg]S
1811-10-29Diastolic blood pressure76mm[Hg]S
1811-10-29Heart rate72/minS
1811-10-29Respiratory rate14/minS
1811-10-29Body temperature36.6CelS
1811-10-29Oxygen saturation in Arterial blood by Pulse oximetry99%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1811-10-29Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]0{score}S
1811-10-29Total score [AUDIT-C]2{score}S

Physical Exam

Vital signs recorded on 1811-10-29; see the Vital Signs section. [S]

SystemFinding
ConstitutionalWell-appearing; BMI 23.9
EyesPupils equal and reactive
NeckNo thyroid enlargement or nodes
CardiovascularRegular rhythm; no murmur; no edema
RespiratoryClear
Breasts and chest wallRight mastectomy scar healed; flap flat with no fluid; left breast without masses
Lymph nodesNo axillary or supraclavicular nodes
ExtremitiesArm circumference 26.0 cm on each side 10 cm above the elbow; right shoulder flexion 165 degrees
AbdomenSoft; no masses
SkinNo suspicious lesions
PsychiatricBright, observant, and engaged

Problems

ProblemClinical statusVerificationCodeProvenance
Invasive ductal carcinoma of the right breast, upper outer quadrant at 10 o'clock, presenting as a firm lump after about a year of breast ache; core biopsy: grade 2, estrogen and progesterone receptor positive, HER2 negative; clinical stage T2 N0 (cT2 cN0 M0); synthetic modern diagnosis linked to the documented 1811 breast disease and mastectomy, whose cancer diagnosis is debatedactiveconfirmed C50.411S — Synthetic diagnosis confirmed by biopsy and surgical pathology in the modern episode; whether her historical disease was cancer remains a retrospective interpretation (R).
Estrogen receptor positive status of the breast cancer (ER 95 percent, PR 70 percent)activeconfirmed Z17.0S — Synthetic receptor result; no tissue from her lifetime was examined.
Absence of the right breast after total mastectomy without reconstruction, her choiceactiveconfirmed Z90.11S — Synthetic coding of the modern mastectomy, which echoes the documented operation.
Long-term use of anastrozole as adjuvant endocrine therapyactiveconfirmed Z79.811S — Synthetic treatment status.
Low bone mass (osteopenia) on baseline DXA before anastrozole: lumbar spine T-score -1.4, femoral neck -1.7; 10-year major osteoporotic fracture risk about 8 percent (FRAX); vitamin D insufficiencyactiveconfirmed M85.80S — Synthetic finding on the baseline DXA the protocol requires for an aromatase inhibitor.
Seroma under the right mastectomy flap after drain removal, without infection; aspirated once by the breast surgery team; resolvedresolvedconfirmed L76.34S — Synthetic common complication of the synthetic mastectomy; it does not echo a documented illness.
Firm lump in the upper outer quadrant of the right breast after about a year of heavy breast ache; clinically suspicious, imaging and biopsy bookedresolvedconfirmed N63.11S — Synthetic presenting concern at the index visit, superseded by the biopsy diagnosis; the year of breast ache echoes her documented account (D).

Assessment and Plan

Personalized prevention plan. A written copy was given to the patient. [S]

ServiceStatusDetail
Influenza vaccine, 1811-1812Completed todayInactivated vaccine given today
Pneumococcal vaccineCompleted todayPCV20 given today; recommended from age 50; no further doses needed
Recombinant zoster vaccineCompleted todayDose 1 today; dose 2 in two to six months
COVID-19 vaccine, 1811-1812DueRecommended; she will get it at her pharmacy in two weeks
Hepatitis B vaccineDueRecommended for adults 19 to 59; series to start at the next visit if the screening test shows no immunity
Tetanus boosterUp to dateTdap six and a half years ago
Breast cancer screeningNot indicatedReplaced by surveillance: yearly diagnostic mammogram of the left breast from next August
Cervical cancer screeningUp to dateCytology with HPV co-testing three years ago, normal; next in two years
Colorectal cancer screeningUp to dateColonoscopy eight years ago, normal; next at ten years
Osteoporosis screeningUp to dateDXA ten days ago: low bone mass; repeat in two years on anastrozole
Hepatitis B, hepatitis C, and HIV screeningOrderedOne-time screening; no prior result on record; drawn today, results pending
Cholesterol screening and statin decisionCompleted todayLipid panel ten days ago reviewed; 10-year risk below 5 percent; no statin
Diabetes screeningNot indicatedBMI 23.9 without other risk factors
Lung cancer screeningNot indicatedNever smoker
Blood pressure screeningCompleted today120/76 mmHg
Depression screeningCompleted todayPHQ-2 score 0
Unhealthy alcohol use screeningCompleted todayAUDIT-C 2, negative
Physical activity and diet counselingCompleted today150 minutes of walking a week, strength exercise twice a week once the surgeon allows, and calcium from food

Immunizations given today: Influenza vaccine, 1811-1812 season; Pneumococcal conjugate vaccine PCV20; Recombinant zoster vaccine, dose 1 of 2 [S]

Guideline basis: Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026); USPSTF A and B Recommendations (2026); Adult Immunization Schedule by Age (2026)

Follow-up: Hepatitis B, hepatitis C, and HIV results by portal message. Second zoster dose in two to six months. Survivorship visit in three months. [S]

Advance Care Planning

Voluntary advance care planning discussion of about 20 minutes, with her consent, prompted by her cancer diagnosis. She has named a health care agent and completed a written health care directive today, now scanned into the chart. She wants to be told plainly and in advance what any treatment would involve. If the cancer returned she would want treatment that offered a real chance of control while she could still live independently and write; she would not want resuscitation or prolonged life support if recovery to independent life were not expected. [S]